XPA tumor variant leads to defects in NER that sensitize cells to cisplatin.
Blee AM, Gallagher KS, Kim HS, Kim M, Kharat SS, Troll CR, D'Souza A, Park J, Neufer PD, Schärer OD, Chazin WJ.
Blee AM, et al. Among authors: neufer pd.
NAR Cancer. 2024 Mar 18;6(1):zcae013. doi: 10.1093/narcan/zcae013. eCollection 2024 Mar.
NAR Cancer. 2024.
PMID: 38500596
Free PMC article.